核受体
过氧化物酶体增殖物激活受体
转录因子
视黄醇X受体
受体
PPAR激动剂
发起人
生物
药理学
医学
内分泌学
内科学
生物化学
基因表达
基因
作者
Joel P. Berger,David E. Moller
出处
期刊:Annual Review of Medicine
[Annual Reviews]
日期:2002-02-01
卷期号:53 (1): 409-435
被引量:2451
标识
DOI:10.1146/annurev.med.53.082901.104018
摘要
The peroxisome proliferator-activated receptors (PPARs) are a group of three nuclear receptor isoforms, PPAR gamma, PPAR alpha, and PPAR delta, encoded by different genes. PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters. PPARs bind as heterodimers with a retinoid X receptor and, upon binding agonist, interact with cofactors such that the rate of transcription initiation is increased. The PPARs play a critical physiological role as lipid sensors and regulators of lipid metabolism. Fatty acids and eicosanoids have been identified as natural ligands for the PPARs. More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, have proven effective in the treatment of dyslipidemia and diabetes. Use of such ligands has allowed researchers to unveil many potential roles for the PPARs in pathological states including atherosclerosis, inflammation, cancer, infertility, and demyelination. Here, we present the current state of knowledge regarding the molecular mechanisms of PPAR action and the involvement of the PPARs in the etiology and treatment of several chronic diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI